Increasing use of NOAC and antiplatelet combination therapy in atrial fibrillation following myocardial infarction or percutaneous coronary intervention

C. Sindet-Pedersen; L. Staerk; M. Lamberts; J. S. Berger; A. Nissen Bonde; J. Langtved Pallisgaard; Christian Torp-Pedersen; G. Gislason; J. Bjerring Olesen

doi:10.1093/eurheartj/ehx504.2876

Increasing use of NOAC and antiplatelet combination therapy in atrial fibrillation following myocardial infarction or percutaneous coronary intervention

C. Sindet-Pedersen, L. Staerk, M. Lamberts, J. S. Berger, A. Nissen Bonde, J. Langtved Pallisgaard, Christian Torp-Pedersen, G. Gislason, J. Bjerring Olesen

Research output: Contribution to journal › Conference abstract in journal › Research › peer-review

Original language	English
Article number	2876
Journal	European Heart Journal
Volume	38
Issue number	Suppl. 1
Pages (from-to)	616
ISSN	0195-668X
DOIs	https://doi.org/10.1093/eurheartj/ehx504.2876
Publication status	Published - 2017
Event	ESC Congress, European Society of Cardiology - Barcelona, Spain Duration: 26 Aug 2017 → 30 Aug 2017

Conference

Conference	ESC Congress, European Society of Cardiology
Country/Territory	Spain
City	Barcelona
Period	26/08/2017 → 30/08/2017

Access to Document

10.1093/eurheartj/ehx504.2876

AUB Link

Search for the material in Aalborg University Library's search engine

Cite this

Sindet-Pedersen, C., Staerk, L., Lamberts, M., Berger, J. S., Bonde, A. N., Pallisgaard, J. L., Torp-Pedersen, C., Gislason, G., & Olesen, J. B. (2017). Increasing use of NOAC and antiplatelet combination therapy in atrial fibrillation following myocardial infarction or percutaneous coronary intervention. European Heart Journal, 38(Suppl. 1), 616. Article 2876. https://doi.org/10.1093/eurheartj/ehx504.2876

@article{6153b80f8882465c9d03e907b435fe3a,

title = "Increasing use of NOAC and antiplatelet combination therapy in atrial fibrillation following myocardial infarction or percutaneous coronary intervention",

author = "C. Sindet-Pedersen and L. Staerk and M. Lamberts and Berger, {J. S.} and Bonde, {A. Nissen} and Pallisgaard, {J. Langtved} and Christian Torp-Pedersen and G. Gislason and Olesen, {J. Bjerring}",

year = "2017",

doi = "10.1093/eurheartj/ehx504.2876",

language = "English",

volume = "38",

pages = "616",

journal = "European Heart Journal",

issn = "0195-668X",

publisher = "Oxford University Press",

number = "Suppl. 1",

note = "ESC Congress, European Society of Cardiology ; Conference date: 26-08-2017 Through 30-08-2017",

}

Sindet-Pedersen, C, Staerk, L, Lamberts, M, Berger, JS, Bonde, AN, Pallisgaard, JL, Torp-Pedersen, C, Gislason, G & Olesen, JB 2017, 'Increasing use of NOAC and antiplatelet combination therapy in atrial fibrillation following myocardial infarction or percutaneous coronary intervention', European Heart Journal, vol. 38, no. Suppl. 1, 2876, pp. 616. https://doi.org/10.1093/eurheartj/ehx504.2876

Increasing use of NOAC and antiplatelet combination therapy in atrial fibrillation following myocardial infarction or percutaneous coronary intervention. / Sindet-Pedersen, C.; Staerk, L.; Lamberts, M. et al.
In: European Heart Journal, Vol. 38, No. Suppl. 1, 2876, 2017, p. 616.

Research output: Contribution to journal › Conference abstract in journal › Research › peer-review

TY - ABST

T1 - Increasing use of NOAC and antiplatelet combination therapy in atrial fibrillation following myocardial infarction or percutaneous coronary intervention

AU - Sindet-Pedersen, C.

AU - Staerk, L.

AU - Lamberts, M.

AU - Berger, J. S.

AU - Bonde, A. Nissen

AU - Pallisgaard, J. Langtved

AU - Torp-Pedersen, Christian

AU - Gislason, G.

AU - Olesen, J. Bjerring

PY - 2017

Y1 - 2017

U2 - 10.1093/eurheartj/ehx504.2876

DO - 10.1093/eurheartj/ehx504.2876

M3 - Conference abstract in journal

SN - 0195-668X

VL - 38

SP - 616

JO - European Heart Journal

JF - European Heart Journal

IS - Suppl. 1

M1 - 2876

T2 - ESC Congress, European Society of Cardiology

Y2 - 26 August 2017 through 30 August 2017

ER -